Product code KJI— Clinical Toxicology

ADVANCE TM EMIT(R) & TM AMIKACIN ASSAY

Classification name
Radioimmunoassay, Kanamycin
Device class
Class 2
Regulation
21 CFR 862.3520
Advisory panel
Clinical Toxicology
Total cleared
6
First cleared
Most recent

Market context for product code KJI

FDA has cleared 6 devices under product code KJI between 1978 and 1983, filed by 6 applicant companies. No FDA device recalls reference this product code. Class II devices are moderate-risk and subject to general and special controls; most reach market through 510(k) clearance by demonstrating substantial equivalence to a predicate device.

Clearances per year

Top applicants under product code KJI

Recent clearances under product code KJI

Data sourced from openFDA. This site is unofficial and independent of the FDA.